Cargando…
Peripheral T-Cell Lymphomas: Therapeutic Approaches
SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104854/ https://www.ncbi.nlm.nih.gov/pubmed/35565460 http://dx.doi.org/10.3390/cancers14092332 |
_version_ | 1784707896436588544 |
---|---|
author | Sibon, David |
author_facet | Sibon, David |
author_sort | Sibon, David |
collection | PubMed |
description | SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of current treatments in nodal PTCL. ABSTRACT: Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare neoplasms of mature T cells or natural killer (NK) cell. PTCLs usually have an aggressive course and a poor outcome. In recent years, significant progress has been made in the knowledge of the molecular lymphomagenesis of PTCLs, and through the development of new, more specific therapeutic molecules, one can hope in the coming years for more personalized medicine and improved patient prognosis. This review aims to provide an up-to-date overview of the current therapeutic approaches in nodal PTCLs. |
format | Online Article Text |
id | pubmed-9104854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91048542022-05-14 Peripheral T-Cell Lymphomas: Therapeutic Approaches Sibon, David Cancers (Basel) Review SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of current treatments in nodal PTCL. ABSTRACT: Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare neoplasms of mature T cells or natural killer (NK) cell. PTCLs usually have an aggressive course and a poor outcome. In recent years, significant progress has been made in the knowledge of the molecular lymphomagenesis of PTCLs, and through the development of new, more specific therapeutic molecules, one can hope in the coming years for more personalized medicine and improved patient prognosis. This review aims to provide an up-to-date overview of the current therapeutic approaches in nodal PTCLs. MDPI 2022-05-08 /pmc/articles/PMC9104854/ /pubmed/35565460 http://dx.doi.org/10.3390/cancers14092332 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sibon, David Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title | Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title_full | Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title_fullStr | Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title_full_unstemmed | Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title_short | Peripheral T-Cell Lymphomas: Therapeutic Approaches |
title_sort | peripheral t-cell lymphomas: therapeutic approaches |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104854/ https://www.ncbi.nlm.nih.gov/pubmed/35565460 http://dx.doi.org/10.3390/cancers14092332 |
work_keys_str_mv | AT sibondavid peripheraltcelllymphomastherapeuticapproaches |